GRS News

At Global Regulatory Services (GRS), we’ve always believed that innovation in healthcare must be met with integrity, compliance, and a deep understanding of regulatory frameworks. Today, we’re proud to announce that GRS is officially a member of the Cannabis Industry Council (CIC)—a positive step forward in our mission to support the rapidly evolving medicinal cannabis sector both in the UK and internationally. 

 

A Growing Industry with Growing Needs 

As the medicinal cannabis industry continues to gain traction across the globe, the demand for high-quality, compliant, and ethically developed products has never been higher. From patient advocacy and pharmaceutical-grade cultivation to research and clinical application—this is a sector with momentum. 

But with great potential comes great complexity. 

 

Manufacturers often face a maze of regional regulations, quality standards, and market access barriers that can delay progress or derail promising innovations. That’s where we come in. 

 

Why We Joined the CIC 

The Cannabis Industry Council represents a united voice for the UK cannabis sector, bringing together thought leaders across medical cannabis, CBD, and hemp. By joining this influential body, GRS strengthens its ability to contribute meaningfully to policy discussions, support educational initiatives, and collaborate with industry pioneers. 

More importantly, it signals our long-term commitment to helping medicinal cannabis businesses thrive in a regulated world and thereby ensuring that patients in need have access to high quality and safe product. 

 

“Our membership in the CIC is more than symbolic—it’s strategic. We are here to serve as a trusted bridge between innovation and regulation, ensuring our clients’ products meet the highest standards, from seed to shelf.” 
— Greer Deal, Co-Founder & Director, Global Regulatory Services 

 

Supporting Manufacturers at Every Step 

Whether you are preparing for launch in the UK, seeking to navigate EU regulatory frameworks, or looking at opportunities beyond Europe, GRS offers unmatched expertise in: 

• Regulatory strategy and market entry 

• Cultivation and extraction 

• GxP compliance (GACP, GMP, GDP, GCP etc) 

• Quality Management Systems and audit readiness 

• Controlled Drug licences 

• Product dossier preparation -‘Specials’ or full Marketing Authorisation 

• Risk management and post-market surveillance 

• Borderline and combination products e.g. device-drug delivery  

 

Our global network of professionals understands the nuances of the cannabis space—because regulation isn’t just about compliance; it’s about enabling safe, reliable, and sustainable growth. 

 

Your Journey, Our Expertise 

At GRS, we view ourselves not just as consultants, but as long-term partners in your journey. Whether you’re a start-up with a novel therapeutic product or a mature company expanding into new markets, we’re ready to walk that road with you. 

 

Regulations can be daunting—but with the right guidance, they become a competitive advantage. 

Stay tuned as we roll out more updates, insights, and resources for medicinal cannabis businesses through our partnership with the CIC. 

 

Want to speak to an expert? Get in touch with us - https://globalregulatoryservices.com/global-regulatory-services-contact-details